GENMAB A/S (GMAB)

Nasdaq · Pharmaceutical Preparations

What they're doing

Not enough recent activity to summarise.

Signals, last 12 months

  1. Insider purchase
    GENMAB A/S (ten_percent_owner) bought $102.1M of stock
  2. Insider purchase
    GENMAB A/S (ten_percent_owner) bought $13.8M of stock
  3. Insider purchase
    GENMAB A/S (ten_percent_owner) bought $289k of stock
  4. Insider purchase
    GENMAB A/S (ten_percent_owner) bought $9.3M of stock
  5. Insider purchase
    GENMAB A/S (ten_percent_owner) bought $54.4M of stock
  6. Insider purchase
    GENMAB A/S (ten_percent_owner) bought $1.5M of stock
  7. Insider purchase
    GENMAB A/S (ten_percent_owner) bought $6.4M of stock
  8. Insider purchase
    GENMAB A/S (ten_percent_owner) bought $20.6M of stock
  9. Insider purchase
    GENMAB A/S (ten_percent_owner) bought $14.6M of stock
  10. Insider purchase
    GENMAB A/S (ten_percent_owner) bought $11.7M of stock

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2025-12-29GENMAB A/Sten percent ownerP1,052,80697$102,122,182
2025-12-29GENMAB A/Sten percent ownerP75,867,19997$7,359,118,303
2025-12-26GENMAB A/Sten percent ownerP2,97897$288,866
2025-12-26GENMAB A/Sten percent ownerP142,61097$13,833,170
2025-12-24GENMAB A/Sten percent ownerP96,08297$9,319,954
2025-12-23GENMAB A/Sten percent ownerP561,04297$54,421,074
2025-12-22GENMAB A/Sten percent ownerP15,71097$1,523,870
2025-12-19GENMAB A/Sten percent ownerP66,26497$6,427,608
2025-12-18GENMAB A/Sten percent ownerP212,17797$20,581,169
2025-12-17GENMAB A/Sten percent ownerP150,79597$14,627,115
2025-12-16GENMAB A/Sten percent ownerP120,75297$11,712,944

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings